This Peer Exchange® centers on navigating the complexities of drug pricing, market access, and reimbursement through the balance of regulatory, payer, and patient perspectives using modern innovative approaches, partnerships, and technologies.
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
JP Morgan 2026: AbbVie Advances its Pipeline
3
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
4
President Trump Asks Congress to Enact 'The Great Healthcare Plan:' Report
5